AI assistant
Sending…
Skye Bioscience, Inc. — Director's Dealing 2018
Mar 3, 2018
34097_dirs_2018-03-02_1e258ba3-1b8d-40c5-9a69-ca9c7018a753.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2018-01-24
Reporting Person: Emerald Health Sciences Inc. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-24 | Common Stock | X | 1781250 | $0.001 | Acquired | 40781250 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-24 | Common Stock Warrant (Right to Buy) | $0.001 | X | 1781250 | Disposed | 2020-08-20 | Common Stock (1781250) | Direct |
More from Skye Bioscience, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Delisting Announcement
2026
May 15
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 3
Delisting Announcement
2026
Mar 19
Board/Management Information
2026
Feb 20
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10